Belgian liquid biopsy specialist Biocartis Group NV has announced it will co-develop a breast cancer assay...
Up To Date
Latest News
German Merck KGaA has secured an option on UK’s F-Star Biotechnology Ltd’s preclinical bispecific PD-L1/LAG...
Cambridge-based cancer company Bicycle Therapeutics has raised £40m to advance its clinical pipeline of...
UK-based drug developers and contract manufacturers are set to find partners in the European Economic Area...
Following a private placement worth CHF3m in February, Swiss allosteric modulator specialist Addex...
London-based orphan drug developer AMO Pharma’s drug AMO-02 has been granted FDA fast track status as...
Share
